Handelsbanken Fonder Ab Spring Works Therapeutics, Inc. Transaction History
Handelsbanken Fonder Ab
- $25.3 Billion
- Q3 2024
A detailed history of Handelsbanken Fonder Ab transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, Handelsbanken Fonder Ab holds 23,400 shares of SWTX stock, worth $699,426. This represents 0.0% of its overall portfolio holdings.
Number of Shares
23,400
Previous 19,800
18.18%
Holding current value
$699,426
Previous $746,000
0.54%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding SWTX
# of Institutions
220Shares Held
66.8MCall Options Held
64.7KPut Options Held
150K-
Vanguard Group Inc Valley Forge, PA6.54MShares$196 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.62MShares$168 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.7MShares$111 Million4.57% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.6MShares$108 Million0.02% of portfolio
-
Boxer Capital, LLC San Diego, CA3.42MShares$102 Million7.16% of portfolio
About SpringWorks Therapeutics, Inc.
- Ticker SWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,401,100
- Market Cap $1.87B
- Description
- SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...